- Home
- PGHL vs INBX Comparison
PGHL vs INBX Comparison
Compare PGHL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- INBX
- Stock Information
- Founded
- PGHL 2018
- INBX 2010
- Country
- PGHL Hong Kong
- INBX United States
- Employees
- PGHL N/A
- INBX N/A
- Industry
- PGHL
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- INBX Health Care
- Exchange
- PGHL NYSE
- INBX Nasdaq
- Market Cap
- PGHL 189.6M
- INBX 222.5M
- IPO Year
- PGHL 2024
- INBX 2020
- Fundamental
- Price
- PGHL $10.18
- INBX $13.98
- Analyst Decision
- PGHL
- INBX Hold
- Analyst Count
- PGHL 0
- INBX 1
- Target Price
- PGHL N/A
- INBX N/A
- AVG Volume (30 Days)
- PGHL 108.0K
- INBX 70.4K
- Earning Date
- PGHL 11-26-2024
- INBX 11-14-2024
- Dividend Yield
- PGHL N/A
- INBX N/A
- EPS Growth
- PGHL N/A
- INBX N/A
- EPS
- PGHL 0.05
- INBX 119.38
- Revenue
- PGHL $13,464,430.00
- INBX $1,568,000.00
- Revenue This Year
- PGHL N/A
- INBX N/A
- Revenue Next Year
- PGHL N/A
- INBX N/A
- P/E Ratio
- PGHL $205.77
- INBX $0.12
- Revenue Growth
- PGHL 20.83
- INBX 19.24
- 52 Week Low
- PGHL $3.60
- INBX $10.80
- 52 Week High
- PGHL $22.50
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- INBX 37.51
- Support Level
- PGHL N/A
- INBX $13.27
- Resistance Level
- PGHL N/A
- INBX $14.49
- Average True Range (ATR)
- PGHL 0.00
- INBX 1.00
- MACD
- PGHL 0.00
- INBX -0.23
- Stochastic Oscillator
- PGHL 0.00
- INBX 33.53
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operate in the Hong Kong construction industry, mainly handling transportation of materials excavated from construction sites. Its services principally comprise of (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly includes ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from oil and rock transportation services.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.